-
EC and UK sign agreements for Covid-19 vaccines supply
pharmaceutical-technology
August 18, 2020
The European Commission (EC) and the UK Government have entered into separate agreements for the supply of potential Covid-19 vaccines.
-
UK Govt. Buys 60 Million Doses of Novavax’ COVID-19 Vax Candidate
contractpharma
August 18, 2020
Fujifilm Diosynth Biotechnologies to manufacture antigen component of NVX-CoV2373 in the UK.
-
UK signs deals with J&J, Novavax for COVID-19 vaccine supplies
expresspharma
August 17, 2020
The latest agreements bring Britain’s total number of doses secured to 362 million for a population of 66 million.
-
COVID-19 vaccines to be monitored post-marketing by consortium in UK
europeanpharmaceuticalreview
August 14, 2020
The ‘One Million Post-Authorisation Study’ has been established to monitor the safety and effectiveness of COVID-19 vaccines in real-life conditions.
-
Second COVID-19 peak in the UK can be avoided with testing and tracing, study finds
pharmatimes
August 07, 2020
Research co-led by UCL and the London School of Hygiene & Tropical Medicine has found that a second COVID-19 wave can be prevented if testing and tracing is scale-up in the UK.
-
UK and Valneva to invest in coronavirus vaccine manufacturing
pharmaceutical-technology
August 06, 2020
The UK Government and biotech company Valneva are set to make a joint investment in a manufacturing facility in Livingston, West Lothian as part of an agreement for early access to 60 million doses of the company’s Covid-19 vaccine candidate.
-
UK government reserves Wockhardt production line to fill finish COVID-19 vaccines
europeanpharmaceuticalreview
August 05, 2020
The UK government reserved a production line at Wockhardt for 18 months to ensure the rapid fill finish of COVID-19 vaccines.
-
Medicine suppliers in UK urged to stockpile in preparation for end of Brexit transition period
europeanpharmaceuticalreview
August 05, 2020
The UK government has written an open letter to medicine suppliers, outlining how supply can be maintained after the end of the Brexit transition period.
-
UK to roll out COVID-19 diagnostic that provides results in under two hours
europeanpharmaceuticalreview
August 04, 2020
An initial 450,000 of Oxford Nanopore’s LamPORE test will be used by the UK government as COVID-19 diagnostics, which yield results in under two hours.
-
UK teams up with Wockhardt for vaccine manufacturing services
pharmaceutical-technology
August 04, 2020
The UK Government has partnered with India-based pharmaceutical company Wockhardt for ‘fill and finish’ services to boost vaccine manufacturing in the UK.